LIQUID-PHASE COMPOSITION CONTAINING ALGINIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND COLLOIDAL POLYSACCHARIDE
The present invention relates to a liquid composition including alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide. The liquid composition of the present invention is suitable as a medical biomaterial for tissue repair to elevate mucosal tissues of the stomach...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
07.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a liquid composition including alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide. The liquid composition of the present invention is suitable as a medical biomaterial for tissue repair to elevate mucosal tissues of the stomach and intestines during endoscopic resection. More specifically, the present invention relates to a submucosal injectable pharmaceutical liquid composition for use in endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for medical applications, including alginic acid having a weight average molecular weight of 100,000 to less than 200,000 or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide. The liquid composition of the present invention is suitable for use as a preparation for submucosal local injection that can maintain mucosal elevation for a long time when injected during endoscopic mucosal resection or endoscopic submucosal dissection. |
---|---|
Bibliography: | Application Number: EP20180818009 |